These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 9328841)

  • 1. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1.
    Merle B; Malaval L; Lawler J; Delmas P; Clezardin P
    J Cell Biochem; 1997 Oct; 67(1):75-83. PubMed ID: 9328841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1.
    Clezardin P; Lawler J; Amiral J; Quentin G; Delmas P
    Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):819-27. PubMed ID: 9032471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-osteosarcoma cell interaction is mediated through a specific fibrinogen-binding sequence located within the N-terminal domain of thrombospondin 1.
    Voland C; Serre CM; Delmas P; Clézardin P
    J Bone Miner Res; 2000 Feb; 15(2):361-8. PubMed ID: 10703939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans.
    Wang S; Herndon ME; Ranganathan S; Godyna S; Lawler J; Argraves WS; Liau G
    J Cell Biochem; 2004 Mar; 91(4):766-76. PubMed ID: 14991768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain.
    Merle B; Durussel L; Delmas PD; Clézardin P
    J Cell Biochem; 1999 Dec; 75(3):538-46. PubMed ID: 10536375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment.
    Winnemöller M; Schön P; Vischer P; Kresse H
    Eur J Cell Biol; 1992 Oct; 59(1):47-55. PubMed ID: 1468447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
    Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
    Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.
    Nunes SS; Outeiro-Bernstein MA; Juliano L; Vardiero F; Nader HB; Woods A; Legrand C; Morandi V
    J Cell Physiol; 2008 Mar; 214(3):828-37. PubMed ID: 17879962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin.
    Vogel T; Guo NH; Krutzsch HC; Blake DA; Hartman J; Mendelovitz S; Panet A; Roberts DD
    J Cell Biochem; 1993 Sep; 53(1):74-84. PubMed ID: 8227183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenascin-contactin/F11 interactions: a clue for a developmental role?
    Vaughan L; Weber P; D'Alessandri L; Zisch AH; Winterhalter KH
    Perspect Dev Neurobiol; 1994; 2(1):43-52. PubMed ID: 7530143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-associated proteoheparan sulfate mediates binding and uptake of thrombospondin in cultured porcine vascular endothelial cells.
    Schön P; Vischer P; Völker W; Schmidt A; Faber V
    Eur J Cell Biol; 1992 Dec; 59(2):329-39. PubMed ID: 1493798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides.
    Wilson KE; Li Z; Kara M; Gardner KL; Roberts DD
    J Immunol; 1999 Oct; 163(7):3621-8. PubMed ID: 10490955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
    Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1.
    Yu H; Tyrrell D; Cashel J; Guo NH; Vogel T; Sipes JM; Lam L; Fillit HM; Hartman J; Mendelovitz S; Panel A; Roberts DD
    Arch Biochem Biophys; 2000 Feb; 374(1):13-23. PubMed ID: 10640391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of a cell adhesion site on collagen XIV (undulin).
    Ehnis T; Dieterich W; Bauer M; Schuppan D
    Exp Cell Res; 1998 Mar; 239(2):477-80. PubMed ID: 9521866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndecan binding sites in the laminin alpha1 chain G domain.
    Suzuki N; Ichikawa N; Kasai S; Yamada M; Nishi N; Morioka H; Yamashita H; Kitagawa Y; Utani A; Hoffman MP; Nomizu M
    Biochemistry; 2003 Nov; 42(43):12625-33. PubMed ID: 14580209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombospondin-1 (TSP-1) and TSP-1-derived heparin-binding peptides induce promyelocytic leukemia cell differentiation and apoptosis.
    Bruel A; Touhami-Carrier M; Thomaidis A; Legrand C
    Anticancer Res; 2005; 25(2A):757-64. PubMed ID: 15868907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An IKLLI-containing peptide derived from the laminin alpha1 chain mediating heparin-binding, cell adhesion, neurite outgrowth and proliferation, represents a binding site for integrin alpha3beta1 and heparan sulphate proteoglycan.
    Tashiro K; Monji A; Yoshida I; Hayashi Y; Matsuda K; Tashiro N; Mitsuyama Y
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):119-26. PubMed ID: 10229666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
    Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
    J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.